Over two years into the pandemic, an alarming number of people continue to develop symptoms months after recovering from COVID-19. It’s estimated that anywhere from 10 to 30% of people that have been infected with COVID-19 will develop long COVID symptoms.1 “Long-haulers” report a wide range of physical, mental, and cognitive symptoms — including chronic fatigue,…
New Hampshire Senate Committee Passes No-Prescription Ivermectin Bill
New Hampshire took another step closer to becoming the second state to make human-grade ivermectin available without a prescription. By a late night 3-2 vote on April 26, the Senate Health and Human Services (HHS) Committee, voted that HB1022 “ought to pass” with an amendment that it would expire in two years. On April 27,…
New Hampshire Senate Committee Passes No-Prescription-Ivermectin Legislation
New Hampshire has taken another step toward becoming the second state to make human-grade ivermectin available without a prescription. In a 3–2 vote late on April 26, the Senate Health and Human Services (HHS) Committee voted that HB 1022 “ought to pass” with an amendment that it would expire in two years. On April 27,…
NHS Transgender Treatment of Children ‘Bordering on Ideological’: UK Health Secretary
British Health Secretary Sajid Javid said on Tuesday that the way the nation’s healthcare system currently handles cases of children with gender dysphoria is “bordering on ideological.” Responding to a question, Javid told MPs that he shared concerns about the NHS insisting on children’s perception of their own gender as a starting point for treatment,…
How a Drug for Opioid and Alcohol Addiction Is Helping Treat Long COVID
A drug that’s helping millions of people with opioid or alcohol dependence is also being used to treat those suffering symptoms of long COVID. Naltrexone has been around since 1984 to treat opioid or alcohol addiction. Given in high doses of 50-milligram tablets or a 380-milligram intramuscular injection, the drug works by binding to opioid…
Low-Back Pain and Complementary Health Approaches: What You Need To Know
March 14, 2022
admin
back painBetter LivingBrightChronic & Acute PainfitnesshealthHealth ConditionsLow back paintreatmentwellness
0 Comment
What’s the Bottom Line? What do we know about the effectiveness of complementary health approaches for low-back pain? There’s low- or moderate-quality evidence that a variety of mind and body practices, including acupuncture, electromyography biofeedback, low-level laser therapy, mindfulness-based stress reduction, progressive muscle relaxation, spinal manipulation, tai chi, and yoga, may be helpful for chronic low-back pain. There’s low-quality evidence that acupuncture, massage therapy, and spinal…
Headaches Are of Different Types and Each Has Some Health Reasons, Find Out More
February 19, 2022
admin
BrightheadacheHealth ConditionsHealthsMigraines & HeadachesMind & Bodysignssymptomstreatmentwellness
0 Comment
Knowing which kind of a headache you are experiencing can help you to treat it properly. Here, we have listed six types of headaches together with their symptoms in order to help you make a diagnosis. Although a headache is defined as a pain localized “in any region of the head,” in reality, there are many…
Cancer and Post-Traumatic Stress
In this blog, Sally Crowe reflects on her experiences of post-traumatic stress (PTS) after being diagnosed and treated for a rare cancer, and shares some valuable insights into what she has found can help, or hinder, recovery from this common, but little talked about, consequence of cancer. I was diagnosed and treated for a rare…
Retraining the Brain to Treat Chronic Back Pain
More than 25 million people in the U.S. live with chronic pain. This is pain that lasts for more than three months. The most common type of chronic pain is chronic back pain. Often, no physical cause for this pain can be found. In these cases, it may stem from brain changes that persist after…
Pfizer Bets on Arena’s Promising Bowel Disease Treatment in $6.7 Billion Deal
December 13, 2021
admin
ArenaBETbowelBusiness & EconomyCompanieseconomyHealth NewsMarketsMind & BodyPfizertreatmentUSUS News
0 Comment
Pfizer Inc. said on Monday it would buy drug developer Arena Pharmaceuticals for $6.7 billion in cash, to add a promising treatment candidate that targets diseases affecting the stomach and intestine. The $100 per share offer is double the last closing price of Arena’s shares, which surged 92 percent to $95.90 in premarket trading. This…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`